| Literature DB >> 33803892 |
Xiang Shi1, Ruowei Guan1, Lutan Zhou2, Zhichuang Zuo1, Xuelin Tao1, Pin Wang1, Yanrong Zhou1, Ronghua Yin1, Longyan Zhao1,3, Na Gao1,4, Jinhua Zhao1.
Abstract
Unique fucosylated glycosaminoglycans (FG) have attracted increasing attention for various bioactivities. However, the precise structures of FGs usually vary in a species-specific manner. In this study, HfFG was isolated from Holothuria floridana and purified by anion exchange chromatography with the yield of ~0.9%. HfFG was composed of GlcA, GalNAc and Fuc, its molecular weight was 47.3 kDa, and the -OSO3-/-COO- molar ratio was 3.756. HfFG was depolymerized by a partial deacetylation-deaminative cleavage method to obtain the low-molecular-weight HfFG (dHfFG). Three oligosaccharide fragments (Fr-1, Fr-2, Fr-3) with different molecular weights were isolated from the dHfFG, and their structures were revealed by 1D and 2D NMR spectroscopy. HfFG should be composed of repeating trisaccharide units -{(L-FucS-α1,3-)d-GlcA-β1,3-d-GalNAc4S6S-β1,4-}-, in which sulfated fucose (FucS) includes Fuc2S4S, Fuc3S4S and Fuc4S residues linked to O-3 of GlcA in a ratio of 45:35:20. Furthermore, the heparanase inhibitory activities of native HfFG and oligosaccharide fragments (Fr-1, Fr-2, Fr-3) were evaluated. The native HfFG and its oligosaccharides exhibited heparanase inhibitory activities, and the activities increased with the increase of molecular weight. Additionally, structural characteristics such as sulfation patterns, the terminal structure of oligosaccharides and the presence of fucosyl branches may be important factors affecting heparanase inhibiting activity.Entities:
Keywords: Holothuria floridana; chemical structure; fucosylated glycosaminoglycans; heparanase; oligosaccharide
Year: 2021 PMID: 33803892 PMCID: PMC8003118 DOI: 10.3390/md19030162
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Physicochemical properties of fucosylated glycosaminoglycans isolated from Holothuria floridana (HfFG), low-molecular-weight HfFG (dHfFG) and the purified fragments. HPLC profiles of HfFG and dHfFG (a) and the oligosaccharide fragments with various degrees of polymerization (dp) (d); chromatograms of 1-phenyl-3-methyl-5-pyrazolone (PMP) derivatives of mixed monosaccharide standards and HfFG (b); and conductimetric titration curve of HfFG (c).
Figure 21H NMR spectra of HfFG (a) and dHfFG (b).
Figure 31H NMR spectra of Fr-1 (a), Fr-2 (b), Fr-3 (c) and 13C NMR spectrum of Fr-2 (d).
Figure 41H-1H COSY (a), overlapped spectra (b) of 1H-1H COSY (gray), ROESY (green) and TOCSY (red), 1H-13C HSQC (c) and partial 1H-13C HMBC (d) spectra of Fr-2 and the chemical structure of native HfFG and its oligosaccharides (e). Fuc2S4S, Fuc3S4S and Fuc4S were signed as I, II, III, respectively, and U, A, T represent the GlcA, GalNAc and anTal residues, respectively.
1H/13C NMR chemical shift assignments of Fr-2 (800 MHz, D2O).
| Residue. | Chemical Shift (ppm) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| H/C | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
|
| →3)-β- | H | 4.983 | 3.949 | 4.523 | 4.952 | 4.433 | 4.263/4.119 | ||
| C | 91.58 | 85.93 | 79.13 | 79.79 | 80.38 | 70.6 | ||||
|
| →4)-β- | H | 4.484 | 3.623 | 3.673 | 3.893 | 3.673 | |||
| C | 103.64 | 76.38 | 79.79 | 78.13 | 79.32 | 177.34 | ||||
|
| →3)-β- | H | 4.485 | 3.971 | 3.938 | 4.729 | 3.893 | 4.101/4.184 | ||
| C | 102.58 | 54.05 | 78.9 | 79.05 | 74.53 | 69.88 | 177.76 | 25.3 | ||
|
| α- | H | 5.602 | 4.403 | 4.064 | 4.766 | 4.817 | 1.276 | ||
| C | 99.3 | 77.88 | 67.27 | 83.62 | 69.04 | 18.53 | ||||
|
| α- | H | 5.261 | 3.857 | 4.422 | 4.942 | 4.783 | 1.303 | ||
| C | 101.85 | 69.18 | 77.75 | 81.92 | 68.89 | 18.8 | ||||
|
| α- | H | 5.315 | 3.708 | 3.949 | 4.69 | 4.745 | 1.267 | ||
| C | 102.04 | 71.33 | 71.46 | 83.94 | 68.98 | 18.47 | ||||
|
| H | 4.416 | 3.512 | 3.551 | 3.618 | 3.671 | ||||
| C | 106.4 | 76.63 | 84.19 | 72.6 | 79.32 | 177.76 | ||||
|
| α- | H | 5.493 | 4.357 | 4.079 | 4.596 | 4.452 | 1.167 | ||
| C | 99.17 | 77.88 | 69.18 | 83.83 | 68.89 | 18.35 | ||||
|
| α- | H | 5.273 | 3.856 | 4.437 | 4.933 | 4.769 | 1.167 | ||
| C | 101.55 | 69.1 | 78.06 | 82.13 | 69.1 | 18.5 | ||||
|
| α- | H | 5.187 | 3.711 | 3.93 | 4.511 | 4.408 | 1.144 | ||
| C | 101.19 | 71.33 | 71.46 | 83.55 | 68.98 | 18.35 | ||||
Figure 5Inhibition effects of HfFG and its oligosaccharides on heparanase (mean ± SD, n = 4).
Heparanase inhibitory activities of various samples.
| Sample | Mw | Specific | IC50 | IC50 |
|---|---|---|---|---|
| HfFG | 47,282 | −50° | 11.4 ± 1.39 | 0.24 ± 2.94 |
| Fr-3 | 3652 a | −45° | 2346 ± 409 | 642.3 ± 112 |
| Fr-2 | 2767 | −32° | 2766 ± 381 | 999.4 ± 138 |
| Fr-1 | 1841 | −44° | 4496 ± 590 | 2440 ± 320 |
| Heparin | ~18,000 | -- | 32.3 ± 2.21 | 1.79 ± 0.12 |
| LMWH | ~4500 | -- | 300 ± 29.4 | 66.67 ± 6.53 |
a The Mw of Fr-1, Fr-2 and Fr-3 was calculated by ChemBioDraw Ultra 14.0 software based on the degree of polymerization and the composition of FucS from the integral analysis of their 1H NMR spectra, respectively.